S

SugenTech Inc
KOSDAQ:253840

Watchlist Manager
SugenTech Inc
KOSDAQ:253840
Watchlist
Price: 6 550 KRW 2.34%
Market Cap: ₩109.6B

SugenTech Inc
Investor Relations

Sugentech, Inc. develops in-vitro diagnostic systems and products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2016-11-11. The firm is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The firm distributes its products within the domestic market and to overseas markets, including Indonesia.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Jin Mi
Chief Executive Officer
No Bio Available

Contacts

Address
DAEJEON
DAEJEON
2F, Research Center Research 1, KT Daedeok 2, 70, Yuseong-daero 1689beon-gil, Yuseong-gu
Contacts
+82437102884
www.sugentech.com